Maven Securities »

BioMarin Pharmaceutical shares owned by Maven Securities

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Maven Securities from 13F filings

Historical chart of Maven Securities investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Maven Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Maven Securities

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3M 15k 87.34
2020-12-31 $710k 8.1k 87.65

More positions owned by Maven Securities

Spdr S&p 500 Etf Tr Call Call Option
United States Stl Corp Put Put Option
Spdr S&p 500 Etf Tr Put Put Option
Vaneck Etf Trust Put Put Option
United States Stl Corp Call Call Option
Select Sector Spdr Tr Put Put Option
Invesco Qqq Tr Put Put Option
Capri Holdings Call Call Option
Capri Holdings Put Put Option
Select Sector Spdr Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Ishares Tr Call Call Option
Select Sector Spdr Tr Call Call Option
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Call Call Option

View all positions for Maven Securities

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
State Street Corporation
Viking Global Investors
Capital Research Global Investors
Ameriprise Financial
UBS Group
venBio Select Advisor
Elliott Investment Management
Geode Capital Management
Jpmorgan Chase & Co
Bank of New York Mellon
Pictet Asset Management Holding SA

View all funds holding BioMarin Pharmaceutical